Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus
- PMID: 17940967
- DOI: 10.1086/520589
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus
Abstract
Zaire Ebola virus infection in macaques causes a fatal disease with a pathogenesis similar to that in humans. During several independent therapy studies, we noted altered tissue tropism in 6 rhesus macaques that survived longer than those with a typical disease course. The mean time to death for these 6 macaques was 21.7 days, which is significantly longer than the average mean time to death of 8.3 days for 20 untreated historical control animals. In addition to living significantly longer, these 6 animals exhibited a variety of deteriorating clinical signs with pathologic findings that were not seen in the untreated control animals, as well as the presence of viral antigen in the brain, eye, pancreas, thyroid, and lung. We suggest that treatment extended the time course of the disease and permitted the virus to infect tissues not usually affected in the typical model.
Similar articles
-
Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.Arch Pathol Lab Med. 1996 Feb;120(2):140-55. Arch Pathol Lab Med. 1996. PMID: 8712894
-
Pathogenesis of experimental Ebola virus infection in guinea pigs.J Infect Dis. 1999 Feb;179 Suppl 1:S203-17. doi: 10.1086/514305. J Infect Dis. 1999. PMID: 9988186
-
Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.Microbes Infect. 2011 Oct;13(11):930-6. doi: 10.1016/j.micinf.2011.05.002. Epub 2011 May 25. Microbes Infect. 2011. PMID: 21651988
-
Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.Bull Soc Pathol Exot. 2005 Sep;98(3):210-7. Bull Soc Pathol Exot. 2005. PMID: 16267963 Review.
-
Ebola virus: unravelling pathogenesis to combat a deadly disease.Trends Mol Med. 2006 May;12(5):206-15. doi: 10.1016/j.molmed.2006.03.006. Epub 2006 Apr 17. Trends Mol Med. 2006. PMID: 16616875 Review.
Cited by
-
Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report.Ann Intern Med. 2016 Aug 16;165(4):301-4. doi: 10.7326/M15-3066. Epub 2016 Apr 5. Ann Intern Med. 2016. PMID: 27043004 Free PMC article. No abstract available.
-
Neurological Complications of Ebola Virus Infection.Neurotherapeutics. 2016 Jul;13(3):461-70. doi: 10.1007/s13311-016-0457-z. Neurotherapeutics. 2016. PMID: 27412684 Free PMC article. Review.
-
Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013/ALFQ in rhesus macaques (Macaca mulatta) of Indian and Chinese origin.Malar J. 2019 Nov 27;18(1):377. doi: 10.1186/s12936-019-3014-5. Malar J. 2019. PMID: 31775762 Free PMC article.
-
Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.J Virol. 2021 Nov 23;95(24):e0083321. doi: 10.1128/JVI.00833-21. Epub 2021 Sep 29. J Virol. 2021. PMID: 34586862 Free PMC article.
-
Ebola virus infection: what should be known?N Am J Med Sci. 2014 Nov;6(11):549-52. doi: 10.4103/1947-2714.145458. N Am J Med Sci. 2014. PMID: 25535601 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical